ARTICLE | Clinical News
AFN-1252 regulatory update
November 18, 2013 8:00 AM UTC
Affinium said FDA granted Qualified Infectious Disease Product (QIDP) designation for AFN-1252 to treat acute bacterial skin and skin structure infections (ABSSSI). The small molecule inhibitor of the...